Home > Insider Trading > Filing (0001209191-23-013708)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1557290	A Stuart Arbuckle	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-02-24	4,714	$289.12	61,590	No	4	F	Direct
Common Stock	Disposition	2023-02-27	3,834	$287.16	57,756	No	4	S	Direct
Common Stock	Disposition	2023-02-27	400	$287.59	57,356	No	4	S	Direct
Common Stock	Disposition	2023-02-27	800	$288.92	56,556	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	140	Indirect	401(k)

Footnotes

Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $287.16 (range $286.57 to $287.51).
Open market sales reported on this line occurred at a weighted average price of $287.59 (range $287.57 to $287.60).
Open market sales reported on this line occurred at a weighted average price of $288.92 (range $288.57 to $289.38).